Index RUT
P/E -
EPS (ttm) -2.93
Insider Own 7.08%
Shs Outstand 98.77M
Perf Week 9.62%
Market Cap 113.40M
Forward P/E -
EPS next Y -0.44
Insider Trans 0.72%
Shs Float 92.43M
Perf Month -27.85%
Income -284.23M
PEG -
EPS next Q -0.42
Inst Own 68.98%
Short Float 5.87%
Perf Quarter -38.71%
Sales 147.75M
P/S 0.77
EPS this Y 54.53%
Inst Trans 2.87%
Short Ratio 2.75
Perf Half Y 108.37%
Book/sh -2.07
P/B -
EPS next Y 67.20%
ROA -55.00%
Short Interest 5.43M
Perf Year -93.15%
Cash/sh 2.37
P/C 0.48
EPS next 5Y -
ROE -42790.17%
52W Range 0.33 - 19.47
Perf YTD 28.62%
Dividend Est. -
P/FCF -
EPS past 5Y -23.23%
ROI -
52W High -94.14%
Beta 0.81
Dividend TTM -
Quick Ratio 1.33
Sales past 5Y -2.51%
Gross Margin 87.24%
52W Low 242.03%
ATR (14) 0.17
Dividend Ex-Date -
Current Ratio 1.52
EPS Y/Y TTM 6.75%
Oper. Margin -182.20%
RSI (14) 37.02
Volatility 11.74% 11.34%
Employees 486
Debt/Eq -
Sales Y/Y TTM 4.99%
Profit Margin -192.37%
Recom 4.00
Target Price 1.50
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 18.88%
Payout -
Rel Volume 0.39
Prev Close 1.13
Sales Surprise -30.24%
EPS Surprise -34.12%
Sales Q/Q -21.03%
Earnings May 06 AMC
Avg Volume 1.98M
Price 1.14
SMA20 -8.12%
SMA50 -34.21%
SMA200 -6.81%
Trades
Volume 776,900
Change 0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-23 Downgrade
BofA Securities
Neutral → Underperform
$4 → $2
Jun-26-23 Downgrade
William Blair
Outperform → Mkt Perform
Jun-26-23 Downgrade
Stifel
Buy → Hold
Jun-26-23 Downgrade
Raymond James
Outperform → Mkt Perform
Jun-26-23 Downgrade
BofA Securities
Buy → Neutral
Jun-02-23 Upgrade
Stifel
Hold → Buy
$23 → $32
Jan-31-23 Upgrade
William Blair
Mkt Perform → Outperform
Jan-26-23 Upgrade
Raymond James
Mkt Perform → Outperform
$35
Jan-05-23 Upgrade
BofA Securities
Neutral → Buy
$18 → $27
Sep-22-21 Downgrade
Goldman
Neutral → Sell
$16 → $11
Aug-20-21 Upgrade
Raymond James
Underperform → Mkt Perform
Jul-16-21 Downgrade
Stifel
Buy → Hold
$55 → $29
Jul-16-21 Downgrade
BofA Securities
Buy → Neutral
$29
Apr-07-21 Downgrade
Mizuho
Buy → Neutral
$72 → $29
Apr-07-21 Downgrade
H.C. Wainwright
Buy → Neutral
Mar-31-21 Upgrade
BofA Securities
Neutral → Buy
$47
Mar-02-21 Downgrade
Jefferies
Buy → Hold
$75 → $45
Feb-01-21 Initiated
H.C. Wainwright
Buy
$58
Oct-26-20 Initiated
Raymond James
Underperform
Jul-10-20 Resumed
Stifel
Buy
$71
Show Previous Ratings
Apr-29-24 07:00AM
Apr-24-24 04:02PM
Apr-03-24 09:32AM
(FierceBiotech.com) -31.94%
Apr-02-24 05:46PM
Mar-26-24 07:00AM
03:45PM
Loading…
Mar-20-24 03:45PM
Mar-11-24 07:00AM
Feb-29-24 08:09AM
Feb-27-24 09:59AM
(Thomson Reuters StreetEvents) +14.59%
Feb-26-24 05:50PM
(Associated Press Finance)
04:40PM
04:34PM
04:15PM
04:06PM
04:05PM
07:00AM
Loading…
Feb-20-24 07:00AM
Feb-05-24 07:00AM
Jan-25-24 07:00AM
Dec-09-23 05:02PM
Nov-07-23 11:01AM
10:01AM
(Thomson Reuters StreetEvents)
Nov-06-23 05:33PM
05:30PM
04:10PM
(Associated Press Finance)
04:01PM
Oct-23-23 07:00AM
Aug-31-23 10:15AM
Aug-30-23 11:09AM
Aug-29-23 06:00PM
(American City Business Journals)
04:15PM
09:35AM
Loading…
Aug-16-23 09:35AM
Aug-09-23 09:14AM
Aug-08-23 10:08AM
(Thomson Reuters StreetEvents) -18.64%
08:59AM
Aug-07-23 07:30PM
05:40PM
04:26PM
04:01PM
Jul-31-23 09:00AM
(American City Business Journals) +7.29%
Jul-25-23 10:49AM
(American City Business Journals) -5.74%
07:00AM
Jul-24-23 07:00AM
Jul-21-23 07:17AM
Jul-19-23 10:50AM
(American City Business Journals) -7.03%
Jul-14-23 09:55AM
Jul-11-23 09:35AM
Jul-01-23 08:46AM
Jun-27-23 12:45PM
Jun-26-23 04:04PM
(Investor's Business Daily) -83.12%
11:34AM
07:22AM
07:11AM
07:04AM
Jun-08-23 01:03PM
Jun-07-23 04:03PM
(Investor's Business Daily) -8.44%
11:47AM
07:02AM
06:55AM
Jun-06-23 04:01PM
02:06PM
(Investor's Business Daily)
May-18-23 07:30AM
May-09-23 10:22AM
(Thomson Reuters StreetEvents)
May-08-23 05:15PM
04:12PM
04:01PM
04:00PM
May-05-23 01:19PM
07:37AM
07:30AM
May-03-23 03:43AM
May-01-23 07:00AM
Apr-24-23 07:00AM
Apr-03-23 07:00AM
Mar-24-23 10:21AM
Mar-11-23 03:27AM
Feb-28-23 02:43PM
(Thomson Reuters StreetEvents)
Feb-27-23 05:25PM
04:01PM
07:00AM
Feb-23-23 11:33AM
07:46AM
Feb-22-23 10:00AM
Feb-20-23 10:00AM
Feb-17-23 07:00AM
Feb-02-23 07:00AM
Jan-16-23 09:34AM
Nov-28-22 07:00AM
Nov-09-22 05:15AM
Nov-07-22 05:45PM
04:01PM
04:00PM
Nov-01-22 07:00AM
Oct-31-22 10:00AM
Oct-24-22 07:00AM
Oct-15-22 09:59AM
Sep-23-22 07:30AM
Aug-26-22 07:00AM
Aug-09-22 06:30AM
Aug-08-22 05:35PM
04:01PM
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wettig Thane CEO Mar 07 '24 Buy 1.91 50,000 95,470 470,178 Mar 11 07:06 PM Henderson Jeffrey William Director Sep 01 '23 Sale 1.03 2,000 2,060 28,866 Sep 06 08:54 PM Henderson Jeffrey William Director Aug 04 '23 Sale 1.91 2,000 3,820 30,866 Aug 08 07:10 PM Henderson Jeffrey William Director Jul 11 '23 Sale 2.69 2,000 5,380 32,866 Jul 13 08:28 PM Conterno Enrique A Chief Executive Officer Jul 07 '23 Sale 2.80 1,880 5,264 374,722 Jul 10 07:36 PM Wettig Thane Chief Commercial Officer Jun 23 '23 Sale 16.53 791 13,075 108,261 Jun 26 04:27 PM Chung Christine SVP, China Operations Jun 14 '23 Sale 16.79 6,250 104,925 236,327 Jun 15 08:17 PM Chung Christine SVP, China Operations Jun 13 '23 Sale 17.60 6,250 110,000 242,577 Jun 15 08:17 PM Blaug Suzanne Director Jun 09 '23 Sale 17.20 8,520 146,571 29,594 Jun 09 07:54 PM EDWARDS JEFFREY L Director Jun 09 '23 Sale 17.19 7,889 135,622 33,977 Jun 09 07:53 PM Brennan Aoife Director Jun 09 '23 Sale 17.19 4,733 81,367 27,947 Jun 09 07:55 PM Cravatt Benjamin Director Jun 09 '23 Sale 17.17 3,944 67,717 28,736 Jun 09 07:56 PM Ho Maykin Director Jun 08 '23 Sale 17.44 8,520 148,591 31,501 Jun 09 07:54 PM Henderson Jeffrey William Director Jun 08 '23 Sale 17.46 7,000 122,185 34,866 Jun 09 07:52 PM Conterno Enrique A Chief Executive Officer Jun 07 '23 Sale 17.04 8,897 151,583 376,602 Jun 09 07:10 PM Schoeneck James A Director Jun 07 '23 Sale 18.03 7,100 127,987 73,722 Jun 09 07:51 PM Chung Christine SVP, China Operations Jun 07 '23 Sale 17.04 3,633 61,894 248,827 Jun 09 07:38 PM Eisner Mark EVP, Chief Medical Officer Jun 07 '23 Sale 17.04 2,042 34,792 162,862 Jun 09 07:12 PM Graham Juan Chief Financial Officer Jun 07 '23 Sale 16.99 1,785 30,320 71,083 Jun 09 07:39 PM Wettig Thane Chief Commercial Officer Jun 07 '23 Sale 17.04 1,758 29,951 111,395 Jun 09 07:39 PM Eisner Mark EVP, Chief Medical Officer Jun 02 '23 Sale 18.83 1,090 20,525 164,904 Jun 05 04:22 PM
Index RUT
P/E 18.92
EPS (ttm) 2.11
Insider Own 1.11%
Shs Outstand 126.77M
Perf Week 3.47%
Market Cap 5.07B
Forward P/E 8.97
EPS next Y 4.45
Insider Trans -7.84%
Shs Float 125.65M
Perf Month 0.45%
Income 281.59M
PEG 0.76
EPS next Q 0.69
Inst Own 98.90%
Short Float 6.56%
Perf Quarter 18.50%
Sales 829.25M
P/S 6.11
EPS this Y 27.24%
Inst Trans 3.74%
Short Ratio 8.22
Perf Half Y 19.10%
Book/sh 0.66
P/B 60.37
EPS next Y 26.26%
ROA 15.75%
Short Interest 8.24M
Perf Year 23.18%
Cash/sh 2.64
P/C 15.09
EPS next 5Y 25.00%
ROE 222.07%
52W Range 29.85 - 45.00
Perf YTD 7.98%
Dividend Est. -
P/FCF 13.58
EPS past 5Y -
ROI 17.79%
52W High -11.31%
Beta 1.25
Dividend TTM -
Quick Ratio 5.50
Sales past 5Y 41.16%
Gross Margin 67.91%
52W Low 33.70%
ATR (14) 1.06
Dividend Ex-Date -
Current Ratio 6.64
EPS Y/Y TTM 44.87%
Oper. Margin 40.71%
RSI (14) 55.93
Volatility 3.32% 2.52%
Employees 373
Debt/Eq 18.27
Sales Y/Y TTM 25.62%
Profit Margin 33.96%
Recom 1.36
Target Price 50.50
Option/Short Yes / Yes
LT Debt/Eq 17.89
EPS Q/Q 56.52%
Payout 0.00%
Rel Volume 0.90
Prev Close 39.82
Sales Surprise -0.42%
EPS Surprise 2.68%
Sales Q/Q 26.75%
Earnings May 07 AMC
Avg Volume 1.00M
Price 39.91
SMA20 2.37%
SMA50 -0.19%
SMA200 2.81%
Trades
Volume 902,798
Change 0.23%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-29-24 Initiated
TD Cowen
Outperform
$54
Jul-24-23 Initiated
H.C. Wainwright
Buy
$61
Jul-24-23 Downgrade
Goldman
Buy → Neutral
$43 → $45
May-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$46
Mar-27-23 Resumed
Berenberg
Buy
$58
Mar-16-23 Downgrade
SVB Securities
Outperform → Market Perform
$42
Dec-21-22 Resumed
Morgan Stanley
Overweight
$53 → $65
Nov-28-22 Initiated
Wells Fargo
Overweight
$65
Sep-09-22 Initiated
Morgan Stanley
Overweight
$50
May-23-22 Initiated
SVB Leerink
Outperform
$52
Jun-14-21 Initiated
Evercore ISI
Outperform
May-17-21 Initiated
SVB Leerink
Outperform
$56
May-11-21 Downgrade
Piper Sandler
Overweight → Neutral
$50 → $48
Jan-21-21 Reiterated
The Benchmark Company
Buy
$46 → $59
Dec-17-20 Initiated
Berenberg
Buy
$50
Sep-14-20 Resumed
JP Morgan
Overweight
$28
Jul-01-20 Initiated
The Benchmark Company
Buy
$39
Feb-05-20 Upgrade
Piper Sandler
Neutral → Overweight
$18 → $27
Jan-09-20 Upgrade
BMO Capital Markets
Market Perform → Outperform
$17 → $24
Jan-08-20 Initiated
Goldman
Buy
$24
Show Previous Ratings
May-03-24 04:17AM
Apr-30-24 10:01AM
Apr-25-24 04:45PM
06:00AM
Apr-24-24 09:45AM
08:30AM
Loading…
Apr-23-24 08:30AM
Apr-19-24 12:13PM
Apr-18-24 12:45PM
12:00PM
Apr-04-24 09:40AM
Mar-29-24 06:40AM
Mar-21-24 11:30AM
Mar-19-24 09:40AM
Mar-14-24 01:24AM
Mar-13-24 02:25PM
02:05AM
Loading…
Mar-12-24 02:05AM
Mar-09-24 01:07PM
Feb-29-24 03:15AM
Feb-27-24 08:30AM
Feb-21-24 11:26AM
09:00AM
06:56AM
(Thomson Reuters StreetEvents)
Feb-20-24 05:30PM
05:10PM
04:36PM
04:15PM
(Associated Press Finance)
04:01PM
Feb-14-24 09:15AM
06:49AM
Feb-13-24 10:00AM
04:30PM
Loading…
Feb-08-24 04:30PM
Jan-29-24 04:15PM
Jan-26-24 09:45AM
Jan-25-24 05:29PM
Jan-24-24 12:10PM
Jan-22-24 09:40AM
Jan-18-24 05:01PM
08:30AM
Jan-17-24 04:01AM
Jan-16-24 08:15AM
01:15AM
Jan-12-24 09:25AM
Jan-10-24 09:45AM
Dec-15-23 03:01PM
Dec-14-23 12:45PM
Dec-08-23 09:45AM
Dec-06-23 11:30AM
Dec-05-23 09:40AM
Nov-27-23 08:00AM
Nov-20-23 12:45PM
Nov-17-23 07:03AM
Nov-16-23 09:55AM
09:00AM
Nov-09-23 10:01PM
04:43PM
Nov-08-23 05:19AM
Nov-07-23 11:22AM
(Thomson Reuters StreetEvents) +10.04%
11:21AM
11:06AM
Nov-06-23 06:00PM
05:25PM
05:10PM
04:27PM
(Associated Press Finance)
04:01PM
07:30AM
Oct-30-23 06:35PM
Oct-27-23 08:47AM
Oct-20-23 12:08PM
05:36AM
Oct-19-23 07:32AM
07:15AM
Oct-18-23 05:01AM
Oct-16-23 03:05PM
08:00AM
Oct-13-23 09:45AM
Sep-20-23 05:01AM
Sep-07-23 11:30AM
09:45AM
Sep-05-23 09:40AM
Sep-01-23 09:50AM
Aug-31-23 08:30AM
Aug-30-23 07:17AM
Aug-29-23 04:50AM
Aug-09-23 12:19PM
Aug-08-23 09:00PM
05:40PM
04:32PM
04:01PM
06:20AM
Jul-28-23 12:00PM
06:14AM
06:00AM
Jul-25-23 08:30AM
Jul-18-23 05:39AM
Jul-17-23 01:15AM
Jul-14-23 10:56AM
Jul-13-23 01:15AM
Jun-27-23 09:40AM
Jun-26-23 07:08AM
Jun-21-23 08:00PM
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Apr 17 '24 Option Exercise 8.11 10,000 81,100 178,176 Apr 17 07:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Apr 17 '24 Sale 38.49 10,000 384,890 168,176 Apr 17 07:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Apr 16 '24 Option Exercise 8.11 10,000 81,100 178,176 Apr 17 07:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Apr 16 '24 Sale 38.35 10,000 383,500 168,176 Apr 17 07:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Mar 26 '24 Option Exercise 11.20 11,618 130,160 168,176 Mar 26 07:38 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Mar 13 '24 Option Exercise 10.66 10,000 106,638 166,558 Mar 13 05:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Mar 13 '24 Sale 42.27 10,000 422,730 156,558 Mar 13 05:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Mar 12 '24 Option Exercise 12.07 10,000 120,700 166,558 Mar 13 05:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Mar 12 '24 Sale 41.64 10,000 416,370 156,558 Mar 13 05:22 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Feb 28 '24 Option Exercise 8.11 7,471 60,590 164,029 Feb 28 06:49 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Feb 28 '24 Sale 39.55 10,000 395,463 156,558 Feb 28 06:49 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Feb 27 '24 Sale 39.95 10,000 399,460 159,087 Feb 28 06:49 PM Torley Helen PRESIDENT AND CEO Feb 16 '24 Option Exercise 0.00 37,884 0 685,814 Feb 20 06:49 PM Snyder Mark Howard SVP, GENERAL COUNSEL Feb 16 '24 Option Exercise 0.00 4,796 0 14,257 Feb 20 06:55 PM LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Feb 16 '24 Option Exercise 0.00 10,422 0 18,344 Feb 20 06:53 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Feb 16 '24 Option Exercise 0.00 10,376 0 171,247 Feb 20 06:59 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Feb 15 '24 Option Exercise 0.00 3,386 0 160,529 Feb 16 05:47 PM LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Feb 15 '24 Option Exercise 0.00 1,254 0 11,345 Feb 16 05:41 PM Torley Helen PRESIDENT AND CEO Feb 15 '24 Option Exercise 0.00 13,092 0 651,096 Feb 16 05:39 PM Torley Helen PRESIDENT AND CEO Feb 10 '24 Option Exercise 0.00 31,281 0 654,947 Feb 13 04:12 PM LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Feb 10 '24 Option Exercise 0.00 2,502 0 11,568 Feb 13 04:15 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Feb 10 '24 Option Exercise 0.00 8,133 0 160,044 Feb 13 04:18 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jan 17 '24 Option Exercise 12.07 10,000 120,700 161,911 Jan 18 04:07 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jan 17 '24 Sale 36.00 10,000 360,000 151,911 Jan 18 04:07 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jan 16 '24 Option Exercise 12.07 10,000 120,700 161,911 Jan 18 04:07 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jan 16 '24 Sale 36.00 10,000 360,000 151,911 Jan 18 04:07 PM Snyder Mark Howard SVP, GENERAL COUNSEL Jan 03 '24 Option Exercise 0.00 7,611 0 12,418 Jan 05 04:04 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Dec 13 '23 Option Exercise 12.07 10,000 120,700 161,911 Dec 13 07:48 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Dec 13 '23 Sale 40.39 10,000 403,940 151,911 Dec 13 07:48 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Dec 12 '23 Option Exercise 13.55 10,000 135,547 161,911 Dec 13 07:48 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Dec 12 '23 Sale 39.63 10,000 396,322 151,911 Dec 13 07:48 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Nov 15 '23 Option Exercise 13.81 10,000 138,100 161,911 Nov 16 04:18 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Nov 15 '23 Sale 39.79 10,000 397,880 151,911 Nov 16 04:18 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Nov 14 '23 Option Exercise 14.32 10,000 143,173 160,203 Nov 16 04:18 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Nov 14 '23 Sale 39.08 10,000 390,790 151,911 Nov 16 04:18 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Oct 17 '23 Option Exercise 19.98 10,000 199,800 161,911 Oct 17 07:28 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Oct 17 '23 Sale 36.52 10,000 365,200 151,911 Oct 17 07:28 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sep 19 '23 Option Exercise 19.98 10,000 199,800 161,911 Sep 19 04:09 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sep 19 '23 Sale 39.10 10,000 390,980 151,911 Sep 19 04:09 PM Torley Helen PRESIDENT AND CEO Aug 31 '23 Option Exercise 13.87 10,000 138,700 633,666 Aug 31 05:35 PM Torley Helen PRESIDENT AND CEO Aug 31 '23 Sale 42.82 10,000 428,170 623,666 Aug 31 05:35 PM Torley Helen PRESIDENT AND CEO Aug 30 '23 Option Exercise 13.87 10,000 138,700 633,666 Aug 31 05:35 PM Torley Helen PRESIDENT AND CEO Aug 30 '23 Sale 42.85 10,000 428,540 623,666 Aug 31 05:35 PM Torley Helen PRESIDENT AND CEO Aug 29 '23 Option Exercise 13.87 10,000 138,700 633,666 Aug 31 05:35 PM Torley Helen PRESIDENT AND CEO Aug 29 '23 Sale 42.40 10,000 424,020 623,666 Aug 31 05:35 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Aug 22 '23 Option Exercise 19.68 10,000 196,778 159,986 Aug 23 05:08 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Aug 22 '23 Sale 42.41 10,000 424,070 151,911 Aug 23 05:08 PM Torley Helen PRESIDENT AND CEO Aug 17 '23 Option Exercise 13.87 10,000 138,700 633,666 Aug 17 05:29 PM Torley Helen PRESIDENT AND CEO Aug 17 '23 Sale 43.18 10,000 431,820 623,666 Aug 17 05:29 PM Torley Helen PRESIDENT AND CEO Aug 16 '23 Option Exercise 13.87 10,000 138,700 633,666 Aug 17 05:29 PM Torley Helen PRESIDENT AND CEO Aug 16 '23 Sale 43.53 10,000 435,320 623,666 Aug 17 05:29 PM Torley Helen PRESIDENT AND CEO Aug 15 '23 Option Exercise 13.87 10,000 138,700 633,666 Aug 17 05:29 PM Torley Helen PRESIDENT AND CEO Aug 15 '23 Sale 43.77 10,000 437,680 623,666 Aug 17 05:29 PM Daly James M Director Aug 14 '23 Sale 43.74 10,000 437,410 20,503 Aug 15 04:04 PM Daly James M Director Aug 11 '23 Sale 43.71 10,000 437,110 30,503 Aug 15 04:04 PM Torley Helen PRESIDENT AND CEO Jul 27 '23 Option Exercise 13.87 10,000 138,700 633,666 Jul 27 04:03 PM Torley Helen PRESIDENT AND CEO Jul 27 '23 Sale 43.79 10,000 437,900 623,666 Jul 27 04:03 PM Torley Helen PRESIDENT AND CEO Jul 26 '23 Option Exercise 13.87 10,000 138,700 633,666 Jul 27 04:03 PM Torley Helen PRESIDENT AND CEO Jul 26 '23 Sale 42.69 10,000 426,890 623,666 Jul 27 04:03 PM Torley Helen PRESIDENT AND CEO Jul 25 '23 Option Exercise 13.87 10,000 138,700 633,666 Jul 27 04:03 PM Torley Helen PRESIDENT AND CEO Jul 25 '23 Sale 42.80 10,000 427,960 623,666 Jul 27 04:03 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jul 18 '23 Option Exercise 15.30 20,000 306,098 151,911 Jul 19 04:10 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jul 18 '23 Sale 40.43 10,000 404,300 141,911 Jul 19 04:10 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jun 21 '23 Option Exercise 18.41 10,000 184,100 151,911 Jun 22 06:20 PM LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Jun 21 '23 Sale 36.00 10,000 360,000 141,911 Jun 22 06:20 PM
Index NDX, S&P 500
P/E 24.14
EPS (ttm) 7.44
Insider Own 0.21%
Shs Outstand 1.11B
Perf Week 8.44%
Market Cap 200.48B
Forward P/E 15.74
EPS next Y 11.41
Insider Trans -3.64%
Shs Float 1.11B
Perf Month 5.82%
Income 8.38B
PEG 2.14
EPS next Q 2.26
Inst Own 76.53%
Short Float 1.71%
Perf Quarter 26.78%
Sales 36.41B
P/S 5.51
EPS this Y 18.77%
Inst Trans -0.30%
Short Ratio 2.26
Perf Half Y 62.00%
Book/sh 21.89
P/B 8.21
EPS next Y 14.01%
ROA 16.65%
Short Interest 19.03M
Perf Year 59.21%
Cash/sh 12.41
P/C 14.47
EPS next 5Y 11.29%
ROE 38.26%
52W Range 101.47 - 181.69
Perf YTD 24.21%
Dividend Est. 3.36 (1.87%)
P/FCF 16.36
EPS past 5Y -
ROI 21.49%
52W High -1.13%
Beta 1.26
Dividend TTM 3.20 (1.78%)
Quick Ratio 1.98
Sales past 5Y 11.93%
Gross Margin 55.80%
52W Low 77.04%
ATR (14) 5.13
Dividend Ex-Date May 30, 2024
Current Ratio 2.65
EPS Y/Y TTM -20.11%
Oper. Margin 24.85%
RSI (14) 63.93
Volatility 2.96% 2.44%
Employees 50000
Debt/Eq 0.63
Sales Y/Y TTM -11.36%
Profit Margin 23.03%
Recom 1.95
Target Price 187.43
Option/Short Yes / Yes
LT Debt/Eq 0.59
EPS Q/Q 35.65%
Payout 48.27%
Rel Volume 1.19
Prev Close 180.10
Sales Surprise 0.35%
EPS Surprise 4.92%
Sales Q/Q 1.23%
Earnings May 01 AMC
Avg Volume 8.41M
Price 179.64
SMA20 7.15%
SMA50 7.63%
SMA200 31.77%
Trades
Volume 10,036,884
Change -0.26%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Initiated
The Benchmark Company
Buy
$200
Apr-16-24 Initiated
Evercore ISI
In-line
$177
Feb-01-24 Reiterated
TD Cowen
Outperform
$160 → $170
Feb-01-24 Downgrade
Citigroup
Buy → Neutral
$160
Jan-23-24 Initiated
Cantor Fitzgerald
Neutral
$150
Jan-12-24 Upgrade
Citigroup
Neutral → Buy
$160
Dec-08-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$119 → $132
Aug-09-23 Downgrade
Daiwa Securities
Buy → Outperform
$125
Aug-03-23 Downgrade
Deutsche Bank
Buy → Hold
$130 → $121
Jul-25-23 Reiterated
Susquehanna
Positive
$135 → $145
Jul-24-23 Reiterated
UBS
Neutral
$120 → $130
Jul-20-23 Initiated
Wolfe Research
Outperform
$145
Mar-16-23 Upgrade
Susquehanna
Neutral → Positive
$130 → $140
Mar-02-23 Resumed
Raymond James
Mkt Perform
Jan-23-23 Upgrade
Barclays
Equal Weight → Overweight
$120 → $150
Dec-12-22 Downgrade
Wells Fargo
Equal Weight → Underweight
$105
Nov-16-22 Initiated
Credit Suisse
Outperform
$150
Oct-24-22 Initiated
HSBC Securities
Buy
$180
Oct-11-22 Reiterated
KeyBanc Capital Markets
Overweight
$220 → $170
Jul-29-22 Downgrade
DZ Bank
Buy → Hold
$150
Show Previous Ratings
Today 06:18AM
May-03-24 05:55PM
10:41AM
08:00AM
(Investor's Business Daily)
06:30AM
04:58AM
Loading…
04:58AM
May-02-24 10:26PM
09:40PM
04:57PM
04:27PM
04:25PM
04:13PM
(Investor's Business Daily)
02:38PM
12:58PM
12:35PM
12:29PM
Loading…
12:29PM
(Associated Press Finance)
12:19PM
12:12PM
(The Wall Street Journal)
12:03PM
11:57AM
11:30AM
11:11AM
10:37AM
10:37AM
10:32AM
09:53AM
08:54AM
08:02AM
07:30AM
07:25AM
07:10AM
Loading…
07:10AM
07:03AM
06:52AM
06:47AM
(Thomson Reuters StreetEvents)
06:07AM
06:04AM
06:03AM
06:03AM
06:01AM
06:00AM
05:56AM
05:56AM
05:48AM
05:42AM
03:41AM
01:07AM
12:36AM
May-01-24 09:43PM
09:04PM
08:58PM
08:30PM
07:15PM
06:20PM
05:44PM
05:42PM
05:35PM
05:07PM
05:04PM
(Investor's Business Daily)
04:55PM
04:41PM
04:29PM
04:21PM
04:11PM
(Associated Press Finance)
04:00PM
04:00PM
04:00PM
10:36AM
08:14AM
07:30AM
06:00AM
06:00AM
04:09AM
Apr-30-24 05:38PM
04:28PM
11:42AM
09:22AM
07:30AM
06:00AM
03:05AM
Apr-29-24 04:00PM
03:25PM
10:48AM
09:45AM
07:23AM
Apr-28-24 09:55PM
06:54PM
05:48PM
08:00AM
Apr-27-24 05:59PM
07:00AM
04:45AM
Apr-26-24 04:53PM
09:15AM
06:30AM
Apr-25-24 09:48PM
04:08PM
09:45AM
Apr-24-24 11:18PM
07:43PM
12:38PM
QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
THOMPSON JAMES H Chief Technology Officer May 03 '24 Sale 182.00 8,000 1,456,000 253,893 May 03 05:54 PM Palkhiwala Akash J. CFO & COO Apr 04 '24 Sale 173.49 3,000 520,480 69,343 Apr 04 07:35 PM THOMPSON JAMES H Chief Technology Officer Apr 01 '24 Sale 168.27 8,000 1,346,160 261,893 Apr 02 04:13 PM ACEVEDO SYLVIA Director Mar 10 '24 Option Exercise 0.00 2,056 0 2,110 Mar 11 05:10 PM MCLAUGHLIN MARK D Director Mar 10 '24 Option Exercise 0.00 2,056 0 23,428 Mar 11 05:08 PM LIVERMORE ANN M Director Mar 10 '24 Option Exercise 0.00 2,056 0 32,873 Mar 11 05:08 PM Johnson Gregory N Director Mar 10 '24 Option Exercise 0.00 2,056 0 3,147 Mar 11 05:09 PM Henderson Jeffrey William Director Mar 10 '24 Option Exercise 0.00 2,056 0 6,408 Mar 11 05:09 PM Miller Jamie S Director Mar 10 '24 Option Exercise 0.00 2,056 0 4,159 Mar 11 05:08 PM AMON CRISTIANO R President & CEO Mar 07 '24 Sale 169.60 8,100 1,373,760 16,200 Mar 08 04:10 PM Palkhiwala Akash J. CFO & COO Mar 07 '24 Sale 175.02 7,000 1,225,118 72,343 Mar 11 04:54 PM MARTIN NEIL SVP, Finance and CAO Mar 05 '24 Sale 160.64 689 110,680 0 Mar 05 06:18 PM AMON CRISTIANO R President & CEO Mar 01 '24 Sale 159.50 8,100 1,291,950 24,300 Mar 01 06:25 PM THOMPSON JAMES H Chief Technology Officer Mar 01 '24 Sale 159.39 8,000 1,275,120 269,893 Mar 01 06:40 PM MARTIN NEIL SVP, Finance and CAO Feb 21 '24 Sale 149.83 371 55,587 689 Feb 21 04:57 PM MARTIN NEIL SVP, Finance and CAO Feb 20 '24 Option Exercise 0.00 1,172 0 1,513 Feb 21 04:57 PM AMON CRISTIANO R President & CEO Jan 19 '24 Sale 149.50 8,100 1,210,950 32,400 Jan 19 05:28 PM CATHEY JAMES J Chief Commercial Officer Jan 11 '24 Sale 139.00 1,000 139,000 4,972 Jan 11 05:35 PM AMON CRISTIANO R President & CEO Dec 15 '23 Option Exercise 0.00 23,426 0 244,182 Dec 18 05:55 PM CHAPLIN ANN C General Counsel&Corp Secretary Dec 15 '23 Option Exercise 0.00 4,971 0 12,333 Dec 18 05:53 PM CATHEY JAMES J Chief Commercial Officer Dec 15 '23 Option Exercise 0.00 3,715 0 7,779 Dec 18 05:54 PM ACE HEATHER S Chief Human Resources Officer Dec 15 '23 Option Exercise 0.00 3,806 0 27,880 Dec 18 05:54 PM THOMPSON JAMES H Chief Technology Officer Dec 15 '23 Option Exercise 0.00 10,542 0 283,522 Dec 18 05:53 PM ROGERS ALEXANDER H President QTL & Global Affairs Dec 15 '23 Option Exercise 0.00 7,024 0 35,496 Dec 18 05:53 PM Palkhiwala Akash J. Chief Financial Officer Dec 15 '23 Option Exercise 0.00 8,200 0 83,315 Dec 18 05:53 PM ROGERS ALEXANDER H President QTL & Global Affairs Dec 14 '23 Sale 140.50 12,972 1,822,535 28,472 Dec 15 04:14 PM CATHEY JAMES J Chief Commercial Officer Dec 11 '23 Sale 134.51 1,000 134,510 4,450 Dec 12 04:04 PM MARTIN NEIL SVP, Finance and CAO Nov 29 '23 Sale 130.00 3,098 402,740 247 Nov 29 05:50 PM MARTIN NEIL SVP, Finance and CAO Nov 20 '23 Option Exercise 0.00 4,736 0 4,983 Nov 21 05:09 PM CATHEY JAMES J Chief Commercial Officer Nov 20 '23 Option Exercise 0.00 2,916 0 6,661 Nov 21 05:09 PM CATHEY JAMES J Chief Commercial Officer Nov 13 '23 Sale 124.00 1,000 124,000 3,745 Nov 13 04:29 PM THOMPSON JAMES H Chief Technology Officer Nov 09 '23 Sale 120.11 10,000 1,201,132 243,795 Nov 09 07:48 PM CHAPLIN ANN C General Counsel&Corp Secretary Nov 01 '23 Option Exercise 0.00 5,701 0 9,333 Nov 02 04:27 PM CATHEY JAMES J Chief Commercial Officer Oct 11 '23 Sale 112.28 1,000 112,280 4,745 Oct 11 04:52 PM ROGERS ALEXANDER H President QTL & Global Affairs Oct 02 '23 Sale 110.40 6,001 662,510 25,229 Oct 02 06:35 PM ROGERS ALEXANDER H President QTL & Global Affairs Oct 01 '23 Option Exercise 0.00 11,662 0 35,392 Oct 02 06:35 PM ACE HEATHER S Chief Human Resources Officer Oct 01 '23 Option Exercise 0.00 2,869 0 17,152 Oct 02 06:23 PM AMON CRISTIANO R President & CEO Oct 01 '23 Option Exercise 0.00 29,585 0 201,693 Oct 02 06:23 PM Palkhiwala Akash J. Chief Financial Officer Oct 01 '23 Option Exercise 0.00 10,486 0 65,181 Oct 02 06:35 PM THOMPSON JAMES H Chief Technology Officer Oct 01 '23 Option Exercise 0.00 20,990 0 262,359 Oct 02 06:35 PM THOMPSON JAMES H Chief Technology Officer Sep 13 '23 Sale 113.23 27,962 3,166,098 241,369 Sep 13 06:33 PM CATHEY JAMES J Chief Commercial Officer Sep 11 '23 Sale 111.27 1,000 111,270 5,745 Sep 11 04:36 PM MARTIN NEIL SVP, Finance and CAO Aug 17 '23 Sale 110.19 4,752 523,623 247 Aug 18 04:22 PM CATHEY JAMES J Chief Commercial Officer Aug 11 '23 Sale 114.16 1,000 114,160 6,745 Aug 11 05:40 PM CATHEY JAMES J Chief Commercial Officer May 20 '23 Option Exercise 0.00 7,443 0 10,159 May 22 05:04 PM ACE HEATHER S Chief Human Resources Officer May 20 '23 Option Exercise 0.00 7,198 0 16,772 May 22 05:04 PM MARTIN NEIL SVP, Finance and CAO May 20 '23 Option Exercise 0.00 2,204 0 5,665 May 22 05:04 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite